Literature DB >> 9313755

Risk variable clustering in the insulin resistance syndrome. The Framingham Offspring Study.

J B Meigs1, R B D'Agostino, P W Wilson, L A Cupples, D M Nathan, D E Singer.   

Abstract

Insulin resistance has been hypothesized to unify the clustering of hypertension, glucose intolerance, hyperinsulinemia, increased levels of triglyceride and decreased HDL cholesterol, and central and overall obesity. We tested this hypothesis with factor analysis, a statistical technique that should identify one factor if a single process underlies the clustering of these risk variables. From 2,458 nondiabetic subjects of the Framingham Offspring Study, we collected clinical data, fasting and 2-h postchallenge glucose and insulin levels, and fasting lipid levels. We performed factor analyses separately for men and women in the entire population and among subgroups with features of the insulin resistance syndrome. Subjects ranged in age from 26 to 82 years (mean age 54); 53% were women, 13.4% had impaired glucose tolerance, 27.6% had hypertension, 40% were obese, and 11.6% were hyperinsulinemic, defined by elevated fasting insulin levels. Underlying the clustering of these risk variables were three factors. Fasting and 2-h postchallenge insulin levels, fasting triglyceride and HDL cholesterol levels, BMI, and waist-to-hip ratio were associated with one factor. Fasting and 2-h levels of glucose and insulin were associated with a second factor. Systolic blood pressure, diastolic blood pressure, and BMI were associated with a third factor. Results were similar for men and women and for all subgroups. These results were consistent with more than one independent physiological process underlying risk variable clustering: a central metabolic syndrome (characterized by hyperinsulinemia, dyslipidemia, and obesity), glucose intolerance, and hypertension. Glucose intolerance and hypertension were linked to the central syndrome through shared correlations with insulin levels and obesity. Insulin resistance (reflected by hyperinsulinemia) alone did not appear to underlie all features of the insulin resistance syndrome.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9313755     DOI: 10.2337/diacare.46.10.1594

Source DB:  PubMed          Journal:  Diabetes        ISSN: 0012-1797            Impact factor:   9.461


  82 in total

Review 1.  Strategies and prospects for finding insulin resistance genes.

Authors:  M P Stern
Journal:  J Clin Invest       Date:  2000-08       Impact factor: 14.808

Review 2.  Genetic determinants of diabetes and atherosclerosis.

Authors:  Braxton D Mitchell; Ikhide G Imumorin
Journal:  Curr Atheroscler Rep       Date:  2002-05       Impact factor: 5.113

Review 3.  The metabolic syndrome and related cardiovascular risk.

Authors:  F Ramos; H P Baglivo; A J Ramírez; R Sánchez
Journal:  Curr Hypertens Rep       Date:  2001-04       Impact factor: 5.369

Review 4.  Quantitative trait linkage studies of diabetes-related traits.

Authors:  Robert L Hanson; William C Knowler
Journal:  Curr Diab Rep       Date:  2003-04       Impact factor: 4.810

5.  Insulin resistance is not necessarily an essential element of metabolic syndrome.

Authors:  Rudruidee Karnchanasorn; Horng-Yi Ou; Lee-Ming Chuang; Ken C Chiu
Journal:  Endocrine       Date:  2012-05-29       Impact factor: 3.633

Review 6.  Epidemiology, trends, and morbidities of obesity and the metabolic syndrome.

Authors:  George A Bray; Tracy Bellanger
Journal:  Endocrine       Date:  2006-02       Impact factor: 3.633

Review 7.  Epidemiology of the insulin resistance syndrome.

Authors:  James B Meigs
Journal:  Curr Diab Rep       Date:  2003-02       Impact factor: 4.810

Review 8.  Prevalence of metabolic syndrome and obesity-associated hypertension in the racial ethnic minorities of the United States.

Authors:  Bonita Falkner; Nicole D F H Cossrow
Journal:  Curr Hypertens Rep       Date:  2014-07       Impact factor: 5.369

9.  Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study.

Authors:  H-F Lin; B Boden-Albala; S H Juo; N Park; T Rundek; R L Sacco
Journal:  Diabetologia       Date:  2005-08-04       Impact factor: 10.122

Review 10.  The metabolic syndrome: time for a critical appraisal. Joint statement from the American Diabetes Association and the European Association for the Study of Diabetes.

Authors:  R Kahn; J Buse; E Ferrannini; M Stern
Journal:  Diabetologia       Date:  2005-09       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.